Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates `
2.2. Market Overview

3. Market Dynamics
3.1. Parent Market Analysis: Vaccine Market
3.2. Market Definition
3.3. Key Drivers
3.3.1. Government Immunization Programs To Eradicate Ailments From The Society
3.3.2. Rise In The Cases Of Influenza
3.3.3. Technology Advancement
3.4. Key Restraints
3.4.1. High Cost Of Development
3.4.2. Lengthy Process Of Development

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape

5. Market By Type
5.1. Quadrivalent Vaccine
5.2. Trivalent Vaccine

6. Market By Technology
6.1. Egg-Based Technology
6.2. Cell-Based Technology

7. Market By Age Group
7.1. Pediatric Age Group
7.2. Adult Age Group

8. Market By Delivery Mode
8.1. Injection
8.2. Nasal Spray

9. Geographical Analysis
9.1. Asia Pacific
9.1.1.1. China
9.1.1.2. Japan
9.1.1.3. India
9.1.1.4. South Korea
9.1.1.5. Australia & New Zealand
9.1.1.6. Thailand
9.1.1.7. Indonesia
9.1.1.8. Vietnam
9.1.1.9. Rest Of Asia Pacific

10. Company Profiles
10.1. Merck
10.2. Novartis Ag
10.3. Pfizer Inc
10.4. Sanofi
10.5. Biodiem
10.6. Emergent Biosolutions
10.7. F. Hoffmann-La Roche Ltd
10.8. Glaxosmithkline
10.9. Abbott
10.10. Csl Ltd



List of Figures


List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Asia Pacific Influenza Vaccine Market, Growth Potential, By Type, In 2019
Figure 6: Asia Pacific Influenza Vaccine Market, By Quadrivalent Vaccine, 2020-2028 (In $ Million)
Figure 7: Asia Pacific Influenza Vaccine Market, By Trivalent Vaccine, 2020-2028 (In $ Million)
Figure 8: Asia Pacific Influenza Vaccine Market, Growth Potential, By Technology, In 2019
Figure 9: Asia Pacific Influenza Vaccine Market, By Egg-Based Technology, 2020-2028 (In $ Million)
Figure 10: Asia Pacific Influenza Vaccine Market, By Cell-Based Technology, 2020-2028 (In $ Million)
Figure 11: Asia Pacific Influenza Vaccine Market, Growth Potential, By Age Group, In 2019
Figure 12: Asia Pacific Influenza Vaccine Market, By Pediatric Age Group, 2020-2028 (In $ Million)
Figure 13: Asia Pacific Influenza Vaccine Market, By Adult Age Group, 2020-2028 (In $ Million)
Figure 14: Asia Pacific Influenza Vaccine Market, Growth Potential, By Delivery Mode, In 2019
Figure 15: Asia Pacific Influenza Vaccine Market, By Injection, 2020-2028 (In $ Million)
Figure 16: Asia Pacific Influenza Vaccine Market, By Nasal Spray, 2020-2028 (In $ Million)
Figure 17: Asia Pacific Influenza Vaccine Market, Regional Outlook, 2019 & 2028 (In %)
Figure 18: China Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 19: Japan Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 20: India Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 21: South Korea Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 22: Australia & New Zealand Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 23: Thailand Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 24: Indonesia Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 25: Vietnam Influenza Vaccine Market, 2020-2028 (In $ Million)
Figure 26: Rest Of Asia Pacific Influenza Vaccine Market, 2020-2028 (In $ Million)


List of Tables


List of Tables


TABLE 1: MARKET SNAPSHOT - INFLUENZA VACCINE
TABLE 2: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY AGE GROUP, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY AGE GROUP, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY DELIVERY MODE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY DELIVERY MODE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 10: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: ASIA PACIFIC INFLUENZA VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)